Schott Pharma

Last updated
Schott Pharma AG & Co. KGaA
Company type KGaA with Aktiengesellschaft as partner with unlimited liability
FWB:  1SXP
ISIN DE000A3ENQ51
Industry Healthcare
FoundedAugust 1, 2022;22 months ago (2022-08-01)
Headquarters Mainz, Germany
Key people
Andreas Reisse, CEO
Almuth Steinkühler, CFO
ProductsPharmaceutical drug containment and delivery systems
Revenue€899 million (2022/2023) [1]
Owner Schott AG
Number of employees
4,646 (as of September 30, 2023) [1]
Divisions
  • Drug Containment Solutions
  • Drug Delivery Systems
Website schott-pharma.com

Schott Pharma (stylized as SCHOTT Pharma) is a provider of drug containment solutions and delivery systems for injectable drugs. [2] [3] Headquartered in Mainz, Germany, [4] [5] the company operates in 14 countries. [6]

Contents

History

Filling Schott glass ampoules with medications (1932) Abfullautomat 1932 SCHOTT.jpg
Filling Schott glass ampoules with medications (1932)
Schott & Gen. advertisement for borosilicate glass vials (1923) Druckschrift Fiolenkorper 1923 SCHOTT.jpg
Schott & Gen. advertisement for borosilicate glass vials (1923)

In 1887, Otto Schott developed borosilicate glass, a form of glassware used to reagent bottles and flasks. From 1911, Schott manufactured borosilicate glass tubing for the production of pharmaceutical ampoules and vials. [7]

Schott Pharma was established as a standalone company in 2022 under the name Schott Pharma AG & Co. KGaA [8] [5] through an equity carve-out (or spin-off) from Schott AG, a manufacturer of specialty glass and glass-ceramics. [9] [10]

In the same year, the company announced their plans to present an IPO, but this was reportedly postponed to 2023 due to the Ukraine war. [4] In September 2023, Schott Pharma went public on the Frankfurt Stock Exchange. The IPO was initially priced at 27€ per share, [11] [12] and a potential valuation of up to 4.1 billion euros, [13] but increased the share price to 30€ the following day. [14] The IPO was the largest of the year in Germany. [15] [16] In December 2023, Schott Pharma was included in the SDAX. [17]

Production & Manufacturing

The company is headquartered in Mainz and operates in 16 locations across 14 countries. [18]

Europe

North America

South America

Asia

Products

Schott Pharma develops and manufactures drug containment solutions and delivery systems for injectable drugs, which it supplies to companies in the biotechnology and pharmaceutical industries. [23]

Its business is divided into two divisions:

Governance

Schott Pharma is a subsidiary of SCHOTT AG, who has controlling shares of 77%(as of 2023: 77%). [16] [14] SCHOTT AG is owned by the Carl Zeiss Foundation. [21]

Schott Pharma was listed on the Frankfurt Stock Exchange's SDAX in 2023.

Parent Company Board of Directors

Independent Supervisory Board

In 2023 SCHOTT AG appointed a Supervisory Board for the subsidiary Schott Parma AG as follows: [27] [28]

Financial Results

2022/232023/24
Turnover
Net Profit

Related Research Articles

<span class="mw-page-title-main">DAX</span> Blue chip stock market index

The DAX is a stock market index consisting of the 40 major German blue chip companies trading on the Frankfurt Stock Exchange. It is a total return index. Prices are taken from the Xetra trading venue. According to Deutsche Börse, the operator of Xetra, DAX measures the performance of the Prime Standard's 40 largest German companies in terms of order book volume and market capitalization. DAX is the equivalent of the UK FTSE 100 and the US Dow Jones Industrial Average, and because of its small company selection it does not necessarily represent the vitality of the German economy as a whole.

<span class="mw-page-title-main">Schott AG</span> German glass company

Schott AG is a German multinational glass company specializing in the manufacture of glass and glass-ceramics. Headquartered in Mainz, Rhineland-Palatinate, Germany, it is owned by the Carl Zeiss Foundation. The company's founder and namesake, Otto Schott, is credited with the invention of borosilicate glass.

The TecDAX stock index tracks the performance of the 30 largest German companies from the technology sector. In terms of order book turnover and market capitalization the companies rank below those included in the DAX.

<span class="mw-page-title-main">Otto Schott</span> German chemist, glass technologist, and inventor (1851–1935)

Friedrich Otto Schott (1851–1935) was a German chemist, glass technologist, and the inventor of borosilicate glass. Schott systematically investigated the relationship between the chemical composition of the glass and its properties. In this way, he solved fundamental problems in glass properties, identifying compositions with optical properties that approach the theoretical limit. Schott's findings were a major advance in the optics for microscopy and optical astronomy. His work has been described as "a watershed in the history of glass composition".

<span class="mw-page-title-main">Siltronic</span> Silicon wafer manufacturer

Siltronic AG is a manufacturer of wafers made of hyperpure silicon, the basis for modern micro- and nanotechnology. The Munich-based company is one of the world's leading manufacturers of wafers for the semiconductor industry.

<span class="mw-page-title-main">Patheon</span>

Patheon is a service brand within Thermo Fisher Scientific’s brand portfolio. Contract development and manufacturing organization (CDMO) services offered under the Patheon brand include small molecule API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics and commercial manufacturing and packaging. In 2017, Patheon was acquired by Thermo Fisher Scientific to form its Pharma Services business.

<span class="mw-page-title-main">Fielmann AG</span> German eyewear company

Fielmann Group AG is a German eyewear company.

<span class="mw-page-title-main">Deutsche EuroShop</span> German Real Estate Investment Company

Deutsche EuroShop AG is an internationally active German real estate investment company headquartered in Hamburg. It is the largest German investor in shopping centers, and the country's only publicly traded company to do so exclusively. At the end of 2023, the firm held investments in 21 properties in Germany, Austria, Poland, Czech Republic and Hungary.

<span class="mw-page-title-main">Vetter Pharma</span>

Vetter Pharma-Fertigung GmbH & Co. KG is a German pharmaceutical service provider founded in 1950. It is headquartered in Ravensburg, Baden-Württemberg, and has production sites in Germany, Austria, the United States, as well as sales offices in Singapore, Japan, and South Korea. The company develops, manufactures and packages aseptically prefilled syringes, cartridges, and vials.

<span class="mw-page-title-main">Tritan copolyester</span> Brand of copolymer

Tritan, a copolymer offered by the Eastman Chemical Company since 2007, is a transparent plastic intended to replace polycarbonate, because of health concerns about Bisphenol A (BPA). Tritan is a copolymer made from three monomers: dimethyl terephthalate (DMT), cyclohexanedimethanol (CHDM), and 2,2,4,4-tetramethyl-1,3-cyclobutanediol (CBDO). Tritan (PCTG) is made without using any BPA.

WILCO AG is a company with headquarters in Wohlen (Switzerland), which mainly produces sophisticated equipment for the pharmaceutical industry, as well as for the food, packaging, aerosol and can making industries. The machines are used for leak testing and automated visual inspection of containers, such as medicine bottles, vials, syringes, cartridges, ampoules, Blow-fill seal, IV-Bags, packaging, cans, and pouches. The company is the global market leader for leak detection machines and trendsetter for inspection with a new inspection approach from lab to production.

<span class="mw-page-title-main">Nipro</span> Japanese medical equipment manufacturer

Nipro Corporation is a Japanese medical equipment manufacturing company. Founded in 1954, the company is headquartered in Osaka and is listed on the Tokyo Stock Exchange and the Osaka Securities Exchange. As of 2013 the company has 58 subsidiaries in Japan, Asia, North and South America and Europe. February 2018, the Company enters the endoscope-related business by making Machida Corporation its subsidiary.

Marijn Emmanuel Dekkers is a Dutch-American former pharmaceutical businessman. He was CEO of Bayer AG from 2010 to 2016. He was CEO of Thermo Fisher Scientific Inc. from 2002 to 2009. He was Chairman of Unilever from 2016 to 2019. He is also Founder and Chairman of Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry.

<span class="mw-page-title-main">WuXi Biologics</span> Chinese pharmaceutical company

WuXi Biologics is a global Contract Research Development and Manufacturing Organization (CRDMO) that provides open-access, integrated technology platforms for biologics drug development.

<span class="mw-page-title-main">TeamViewer (company)</span> German technology company

TeamViewer SE is an international technology company headquartered in Göppingen, Germany. The company became known for the TeamViewer remote access and support software of the same name. TeamViewer offers its customers a global platform for connecting, monitoring, and controlling computers, machines, and other devices. TeamViewer's software is used in companies of all sizes and from all industries, for example, to digitalize processes along the industrial value chain. The company is listed on the stock exchange and is a member of MDAX and TecDAX.

HBM Healthcare Investments is a publicly traded Swiss investment and venture capital firm focusing on emerging technologies in the global healthcare sector. Within healthcare their focus is predominantly in biotechnology, medical technology, diagnostics and digital health.

The ZEAL Network SE, headquartered in Hamburg, is an e-commerce group of companies that offers lottery products online. The brands of the ZEAL Group include Lotto24 and Tipp24.

ATOSS Software SE is a publicly listed company that provides software for workforce management.

<span class="mw-page-title-main">Redcare Pharmacy</span> Online pharmacy retailer

Redcare Pharmacy N.V. is a publicly listed mail-order pharmacy retailer headquartered in Sevenum, Netherlands.

Nagarro SE is a German IT service provider based in Munich, Bavaria, Germany. The company was founded in 2020 as a spin-off of Allgeier SE. The company has been listed on the Frankfurt stock exchange since December 2020. Nagarro was included in the SDAX index in June 2021 and in the TecDAX of Deutsche Börse in December 2021. The company's activities include digital products and IT services, particularly for the automotive, energy and telecommunications industries.

References

  1. 1 2 SCHOTT Pharma Annual Report 2022/2023 (accessed February 08, 2024)
  2. ↑ Kansteiner, Fraiser (2023-12-23). "Glass specialist Schott Pharma touts 2023 sales growth, Serbia expansion and hiring plans". Fierce Pharma. Retrieved 2024-04-08.
  3. ↑ "EQS-News: SCHOTT Pharma bestätigt Prognose für das Geschäftsjahr 2024 anlässlich seiner Q2-Ergebnisse; Geschäftsjahr 2025 durch geringeres Wachstum bei Spritzen beeinflusst" [EQS-News: SCHOTT Pharma confirms forecast for the 2024 financial year on the occasion of its Q2 results; financial year 2025 influenced by lower growth in syringes]. 4Investors.de (in German). 2024-05-14. Retrieved 2024-06-24.
  4. 1 2 Ibrahim, Samir (2023-09-28). "Schott Pharma startet erfolgreich an der Frankfurter Börse". tagesschau.de (in German). Retrieved 2024-06-24.
  5. 1 2 3 Nünchert, Ike (2022-08-03). "SCHOTT Pharma: Carve-Out für ein mögliches IPO" [SCHOTT Pharma: Carve-Out for a possible IPO]. Going Public. Retrieved 2024-06-24.
  6. ↑ "Größter Börsengang in 2023: So hat sich die SCHOTT Pharma-Aktie seit ihrem IPO entwickelt - und so könnte es in 2024 nun weitergehen". finanzen.net. 2024-01-24. Retrieved 2024-02-28.
  7. ↑ "Impfstoff-Ampullen – Rohrglas für Lebensretter - VBG Spezial". glaskeramik.org. VBG. 2021-07-04. Retrieved 2024-02-28.
  8. ↑ Dunleavy, Kevin (2023-09-06). "After one year as standalone business, glassmaker Schott Pharma sets course for IPO". Fierce Pharma. Retrieved 2024-06-24.
  9. ↑ Kansteiner, Fraiser (2022-01-08). "Glass maker Schott's pharma business sets out on its own. Will an IPO follow?". Fierce Pharma. Retrieved 2024-02-28.
  10. ↑ Landsteiner, Fraiser (2022-08-01). "Glass maker Schott's pharma business sets out on its own. Will an IPO follow?". Fierce Pharma. Retrieved 2024-06-24.
  11. ↑ Gopinath, Swetha (2023-09-28). "Germany's Schott Raises €813 Million in IPO of Medical-Glass Arm". www.bloomberg.com. Retrieved 2024-06-24.
  12. ↑ gsp (2023-09-29). "Schott Pharma geht mit Freshfields an die Frankfurter Börse" [Schott Pharma goes to the Frankfurt Stock Exchange with Freshfields]. Extrajournal.Net (in German). Retrieved 2024-06-24.
  13. ↑ "Schott Pharma prices IPO at 27 euros per share". Reuters. 2023-09-27. Retrieved 2024-06-24.
  14. 1 2 "SCHOTT Pharma feiert erfolgreiches Börsendebüt: Erstkurs über Ausgabepreis" [SCHOTT Pharma celebrates successful stock market debut: First price on issue price]. Finanzen Net (in German). 2023-09-28. Retrieved 2024-06-24.
  15. ↑ Farr, Emma-Victoria; Mayo Cerqueiro, Pablo (2023-09-28). "Schott Pharma shares jump 16% in Frankfurt trading debut". reuters.com. Reuters. Retrieved 2024-02-28.
  16. 1 2 "Schott Pharma startet erfolgreich an der Börse". tagesschau.de. 2023-09-28. Retrieved 2024-02-28.
  17. ↑ Ingerl, Christian (2023-12-13). "Profitabler Small Cap: Zulieferer Schott Pharma bald im SDax". Capital. Retrieved 2024-02-28.
  18. ↑ "Größter Börsengang in 2023: So hat sich die SCHOTT Pharma-Aktie seit ihrem IPO entwickelt - und so könnte es in 2024 nun weitergehen". finanzen.net. 2024-01-24. Retrieved 2024-02-28.
  19. 1 2 Zeitung, Badische (2022-12-02). "SCHOTT Pharma: Ein globales Kompetenzzentrum in Müllheim". Badische Zeitung (in German). Retrieved 2024-06-24.
  20. ↑ Schlegel, Marion (2023-12-19). "SDAX-Neuling Schott Pharma gibt ordentlich Gas: Zahlen kommen gut an". www.deraktionaer.de (in German). Retrieved 2024-06-24.
  21. 1 2 3 "SCHOTT Pharma baut Produktion in China und Ungarn aus – ZWP online – das Nachrichtenportal für die Dentalbranche". www.zwp-online.info (in German). 2022-09-22. Retrieved 2024-06-24.
  22. 1 2 "SCHOTT: solides Ergebnis trotz konjunktureller Herausforderungen – ZWP online – das Nachrichtenportal für die Dentalbranche" [SCHOTT: solid result despite economic challenges]. www.zwp-online.info (in German). 2024-02-12. Retrieved 2024-06-24.
  23. ↑ SCHOTT Pharma Annual Report 2022/2023, SCHOTT Pharma, p. 14, retrieved 2024-02-28
  24. ↑ Kaiser, Lea (2023-10-24). "Next generation pharma glass: SCHOTT AG launches FIOLAX® Pro Glass tubing". BusinessWire. Retrieved 2024-06-24.
  25. ↑ "Schott Pharma rolls out pre-filled polymer syringes for deep-cold medication". NS Medical Devices. 2023-05-18. Retrieved 2024-02-28.
  26. ↑ Kolf, Ingo (2024-05-15). "Kurs bricht ein: Schott Pharma: Trübe Aussichten führen zu drastischem Kurseinbruch". FinanzNachrichten.de (in German). Retrieved 2024-06-24.
  27. ↑ Mills, Jess (2023-05-02). "Schott appoints Supervisory Board of Schott Pharma". Glass International. Retrieved 2024-06-24.
  28. ↑ "SCHOTT bestellt Aufsichtsrat der SCHOTT Pharma AG" [SCHOTT appoints Supervisory Board of SCHOTT Pharma AG]. ZWP-online. 2023-05-02. Retrieved 2024-06-24.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.